This Project Grant award from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $1,231,538.00 to the Dana-Farber Cancer Institute, Inc. (DFCI) to conduct research on genetic testing, counseling, and management of cancer in Africa. The award period runs from July 1, 2024 to June 30, 2027.
The project involves conducting cancer genetic testing and counseling initiatives in Rwanda, with a focus on building local capacity and integrating these services into the healthcare system. DFCI is collaborating with several sub-awardees in Rwanda, including the King Faisal Hospital Rwanda Foundation, to implement the research protocols and build the necessary infrastructure. Key project activities include training local clinicians, establishing genetic testing and counseling procedures, and collecting data to inform future cancer management strategies in the region.
Generated 1/14/25, 4:55 AM